With an estimated world market share of 8.15% GSK is ranked as one of the top five pharmaceutical companies in the global marketplace. Glaxo Laboratories (Ceylon) Limited founded in 1956‚ achieved number 01 market position by 1986 among private pharmaceutical companies‚ currently operates as two separate SBU’s Glaxo Welcome and SmithKline Beecham since the merger of the two companies in 2001. Employing around 500 staff GSK is one of the most admired companies in Sri Lanka committed to major scale
Premium Pharmaceutical industry
the merger of Glaxo-Wellcome‚ Wellcome-Hallas manager Ofra Sherman found herself in an interesting predicament. With uncertainty as to whether she answered to Wellcome or Promedico‚ she needed to find a way to keep her staff informed and motivated amidst uncertainty of their future. With minimal information‚ she needed to decide who she was going to answer to‚ what she was going to tell her employees‚ and ultimately what direction she was going to take her team in the aftermath of the merger. How
Premium Do the Right Thing
Glaxo Wellcome Inc. Mini-case Report April 2‚ 2007 [pic] Executive Summary Glaxo Wellcome Inc’s primary business is to market prescription products to physicians and health care providers. One of the top three pharmaceutical firms in the world‚ Glaxo Wellcome Inc. held about 4 percent of the worldwide prescription pharmaceutical market. The U.K. based company was formed in 1995 when Glaxo Pharmaceuticals acquired Burroughs Wellcome. While the company is based in the U.K.‚ the U.S. market
Premium Pharmaceutical industry Marketing
How SmithKline Beecham Makes Better Resource-Allocation Decisions In 1993‚ SmithKline Beecham was spending more than half a billion dollars per year on R&D‚ the lifeblood of any pharmaceuticals company. Ever since the 1989 merger that created the company‚ however‚ SB believed that it had been spending too much time arguing about how to value its R&D projects—and not enough time figuring out how to make them more valuable. With more projects successfully reaching late-stage development
Premium Decision making Decision theory Project team
Headaches of GlaxoWellcome ( Migraine medicine is a key growth area for Glaxo Wellcome Inc. (Glaxo); a Britain-based pharmaceutical company with global operations.[1] Glaxo’s primary business is to market prescription products to physicians and healthcare providers. Glaxo was the first pharmaceutical company to manufacture and market a revolutionary new class of prescription migraine medications called “triptans”. Triptans‚ which Glaxo launched in 1993‚ are a class of medications that work specifically
Premium Pharmaceutical industry Marketing
Ratio Analysis & Valuation of Glaxo SmithKline Bangladesh Limited Submitted To: Suborna Barua Course Instructor School of Business‚ UIU Submitted To: Tanvir Ahmed Patwary ID: 111 092 142 Sec: B Date of submission: 9th September‚ 2012 1 United International University Overview of Pharmaceuticals Industry The Pharmaceuticals Industry in Bangladesh is maintaining its momentum of strong double digit growth. In 2010‚ the market exceeded Taka 6 billion (US$ 900m) with a growth of about
Premium Balance sheet Generally Accepted Accounting Principles Inventory
Durham Research Online Deposited in DRO: 22 January 2013 Version of attached file: Accepted Version Peer-review status of attached file: Peer-reviewed Citation for published item: Garrow‚ D. and Yarrow‚ T. (2010) ’Archaeology and anthropology : understanding similarity‚ exploring difference.’‚ Oxford: Oxbow. Further information on publisher’s website: http://www.oxbowbooks.com/bookinfo.cfm/ID/87549 Publisher’s copyright statement: Additional information: Sample chapters deposited
Free Anthropology Archaeology
Do Mergers and Acquisitions always bring desired results? Individual Assignment [pic] [pic] [pic] Student Name: Mandeep Kaur (10211855) Module Leader: Simeon Scott Course: MA- IBM Introduction: For my research topic I have chosen this topic to analyse and to investigate about the mergers and acquisitions of organisations. Do these mergers and acquisitions
Premium Mergers and acquisitions
Reporting. Kaplan Publishing Foulks Lynch ACCA Study Text (2008/09) Paper P2 (INT) Corporate Reporting ACCA Study Text (2008/09) Paper P3 Business Analysis. BPP Learning Media Ltd Annual Report (2006)‚ Glaxo SmithKline Annual Report (2007)‚ Glaxo SmithKline. Annual Report (2008)‚ Glaxo SmithKline Financial Analysis http://www.enotes.com/small-business-encyclopedia/financial-analysis (Visited 05th November 2009) Introduction http://www.roi-ally.com/BPE_vol1.htm (Visited 05th November 2009)
Premium Financial ratio Financial ratios
COMMON LAW ADMISSION TEST 2013 FINAL ALLOTMENT LIST OF CANDIDATES ALLOTED TO VARIOUS NLUs FOR ADMISSION TO THE UNDER-GRADUATE LAW COURSES CAT_H* 1-DEPENDENT OF FREEDOM FIGHTER ; 2- SON/DAUGHTER OF DEFENCE/PERSONNEL DEPLOYED IN UP OR DEFENCE PERSONNEL OF UP EITHER RETIRED OR KILLED/DISABLED IN ACTION ; 3 - ANCESTRAL RESIDENT OF VILLAGE SIDHUWAL‚ DISTRICT PATIALA ; 4- NONE Nationality* 1-INDIAN ; 2-FOREIGN NRI_Status * : 1 - NRI ; 2 - NRI SPONSORED ; 3 - NONE Rs. 50000/NRI Deposited S.No. RollNo
Premium Bihar